Takeda Said to Plan Biggest Japan Bond Sale After Shire Purchase

Takeda Pharmaceutical Co. is planning what would be the biggest single-tranche Japanese corporate yen bond sale in an effort to extend its debt obligations following its $62 billion purchase of Shire Plc, according to people with knowledge of the discussions.

The drug maker is planning to sell as much as 500 billion yen ($4.6 billion) of hybrid notes in the fiscal year starting April 1, said the people, who asked not to be identified because the details are private. That would be the largest-ever public issuance of Japanese corporate bonds in the local market excluding private placements, according to Bloomberg-compiled ...